Your browser is no longer supported. Please, upgrade your browser.
Settings
ILMN [NASD]
Illumina, Inc.
IndexS&P 500 P/E85.90 EPS (ttm)5.20 Insider Own0.20% Shs Outstand146.00M Perf Week-2.44%
Market Cap65.72B Forward P/E89.26 EPS next Y5.01 Insider Trans-9.62% Shs Float145.52M Perf Month-12.46%
Income768.00M PEG3.57 EPS next Q1.13 Inst Own91.80% Short Float1.51% Perf Quarter-2.01%
Sales3.97B P/S16.57 EPS this Y-34.10% Inst Trans-0.23% Short Ratio3.38 Perf Half Y7.48%
Book/sh35.48 P/B12.60 EPS next Y-12.80% ROA9.50% Target Price464.61 Perf Year49.99%
Cash/sh29.15 P/C15.33 EPS next 5Y24.03% ROE15.80% 52W Range260.42 - 555.77 Perf YTD20.81%
Dividend- P/FCF73.19 EPS past 5Y7.40% ROI6.50% 52W High-19.57% Beta0.91
Dividend %- Quick Ratio5.60 Sales past 5Y7.90% Gross Margin68.60% 52W Low71.65% ATR11.56
Employees7800 Current Ratio6.10 Sales Q/Q77.90% Oper. Margin17.00% RSI (14)34.85 Volatility2.00% 2.53%
OptionableYes Debt/Eq0.32 EPS Q/Q296.30% Profit Margin19.40% Rel Volume2.68 Prev Close449.92
ShortableYes LT Debt/Eq0.32 EarningsAug 05 AMC Payout0.00% Avg Volume648.10K Price447.01
Recom2.80 SMA20-3.82% SMA50-7.22% SMA2004.65% Volume1,739,491 Change-0.65%
Aug-19-21Downgrade SVB Leerink Outperform → Mkt Perform $425
Jun-01-21Upgrade Evercore ISI Underperform → In-line $400
Mar-31-21Upgrade Canaccord Genuity Hold → Buy $445
Mar-31-21Downgrade Atlantic Equities Overweight → Neutral $390
Mar-03-21Initiated Barclays Underweight $325
Dec-22-20Upgrade Piper Sandler Neutral → Overweight $340 → $415
Dec-17-20Upgrade BTIG Research Neutral → Buy $410
Oct-13-20Downgrade Guggenheim Buy → Neutral
Sep-30-20Initiated Atlantic Equities Overweight $355
Sep-29-20Downgrade Wolfe Research Outperform → Peer Perform
Sep-22-20Downgrade UBS Buy → Neutral $390 → $285
Sep-22-20Downgrade Stifel Buy → Hold $380 → $280
Sep-21-20Upgrade Guggenheim Neutral → Buy $345
Sep-21-20Downgrade JP Morgan Overweight → Neutral $390 → $280
Sep-09-20Initiated Morgan Stanley Equal-Weight $400
Aug-07-20Downgrade Piper Sandler Overweight → Neutral $356 → $340
Aug-07-20Downgrade Evercore ISI In-line → Underperform $310
Jul-07-20Downgrade Guggenheim Buy → Neutral
Apr-24-20Downgrade Citigroup Buy → Neutral $250 → $320
Apr-21-20Downgrade Robert W. Baird Outperform → Neutral $310
Sep-16-21 07:30AM  
Sep-15-21 09:15AM  
Sep-14-21 07:30AM  
Sep-13-21 02:56PM  
Sep-12-21 07:01PM  
Sep-09-21 09:30AM  
Sep-08-21 08:36AM  
Sep-07-21 10:38AM  
09:15AM  
Sep-04-21 09:55AM  
Sep-03-21 07:30AM  
Sep-02-21 05:43PM  
05:40PM  
Aug-30-21 05:00PM  
Aug-27-21 07:01PM  
Aug-26-21 11:32AM  
Aug-24-21 03:30PM  
03:06PM  
07:38AM  
Aug-23-21 09:00AM  
07:46AM  
01:48AM  
Aug-20-21 10:52AM  
06:27AM  
06:22AM  
05:45AM  
04:02AM  
Aug-19-21 04:02PM  
03:56PM  
01:55PM  
09:49AM  
07:37AM  
06:39AM  
06:18AM  
05:29AM  
Aug-18-21 06:54PM  
06:48PM  
04:38PM  
Aug-17-21 05:40PM  
Aug-14-21 08:12AM  
Aug-12-21 03:20PM  
08:30AM  
07:06AM  
Aug-11-21 06:22AM  
06:00AM  
Aug-09-21 12:26PM  
Aug-08-21 05:00PM  
Aug-06-21 12:45PM  
10:07AM  
09:06AM  
Aug-05-21 11:01PM  
05:25PM  
05:08PM  
04:05PM  
Aug-04-21 12:52PM  
10:39AM  
Aug-03-21 09:30PM  
Jul-30-21 06:35AM  
Jul-29-21 03:05PM  
06:55AM  
Jul-28-21 06:30PM  
Jul-26-21 08:50AM  
Jul-23-21 12:28PM  
06:00AM  
Jul-22-21 12:49PM  
12:39PM  
12:31PM  
12:19PM  
12:19PM  
12:15PM  
Jul-21-21 12:45PM  
03:21AM  
Jul-20-21 12:10PM  
12:00PM  
Jul-19-21 07:07AM  
Jul-14-21 11:50AM  
07:31AM  
Jul-13-21 08:00PM  
05:00PM  
03:18PM  
Jul-08-21 04:44PM  
Jul-03-21 09:00AM  
Jun-30-21 11:30AM  
Jun-28-21 01:12PM  
Jun-25-21 11:58AM  
Jun-22-21 10:03AM  
Jun-18-21 08:22PM  
04:13PM  
Jun-17-21 10:36AM  
05:34AM  
Jun-12-21 06:10AM  
Jun-10-21 08:00AM  
06:43AM  
Jun-09-21 09:08AM  
06:47AM  
Jun-04-21 12:55PM  
09:09AM  
08:37AM  
Jun-01-21 07:40AM  
03:05AM  
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TOUSI SUSAN HSVP, Chief Commercial OfficerAug 30Sale463.50300139,05041,456Sep 01 07:15 PM
Dadswell CharlesSVP & General CounselAug 23Sale489.10314153,5775,286Aug 25 04:40 PM
Hoyt Aimee LSVP, Chief People OfficerAug 04Sale500.00372186,0003,757Sep 08 07:36 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerAug 04Sale500.001,000500,00041,756Aug 05 04:22 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJul 28Sale486.41300145,92342,743Jul 29 04:34 PM
Dadswell CharlesSVP & General CounselJul 22Sale482.23314151,4205,576Jul 26 04:57 PM
Aravanis AlexanderSVP, Chief Technology OfficerJul 07Sale477.59539257,4214,679Jul 07 06:26 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerJun 28Sale478.95300143,68543,043Jun 30 05:27 PM
Hoyt Aimee LSVP, Chief People OfficerJun 24Sale475.00500237,5004,111Sep 08 07:36 PM
Dadswell CharlesSVP & General CounselJun 22Sale461.01314144,7575,890Jun 24 05:41 PM
Febbo Phillip G.SVP Chief Medical OfficerJun 11Sale447.591,000447,5884,461Jun 14 05:50 PM
DORSA CAROLINEDirectorJun 10Sale450.001,000450,0008,501Jun 14 05:48 PM
Hoyt Aimee LSVP, Chief People OfficerJun 10Sale450.00500225,0004,611Sep 08 07:36 PM
Dadswell CharlesSVP & General CounselMay 24Sale403.04314126,5556,204May 26 04:50 PM
TOUSI SUSAN HSVP, Chief Commercial OfficerMay 20Sale400.00500200,00043,343May 24 04:43 PM
FLATLEY JAY TDirectorMay 18Sale379.534,0001,518,120148,933May 20 04:51 PM
TOUSI SUSAN HSVP Product DevelopmentMay 05Sale381.88300114,56443,843May 06 05:26 PM
FLATLEY JAY TDirectorMay 04Sale384.154,0001,536,600152,933May 06 05:21 PM
Dadswell CharlesSVP & General CounselApr 22Sale402.02314126,2346,518Apr 26 07:52 PM
FLATLEY JAY TDirectorApr 20Sale401.834,0001,607,320156,933Apr 22 05:05 PM
Hoyt Aimee LSVP, Chief People OfficerApr 06Sale424.221,000424,2185,111Sep 08 07:36 PM
FLATLEY JAY TDirectorApr 06Sale423.444,0001,693,740160,933Apr 07 04:41 PM
TOUSI SUSAN HSVP Product DevelopmentApr 06Sale423.44500211,71844,143Apr 07 04:34 PM
TOUSI SUSAN HSVP Product DevelopmentApr 05Sale386.03300115,80944,643Apr 07 04:34 PM
Hoyt Aimee LSVP, Chief People OfficerApr 05Sale386.031,000386,0306,111Sep 08 07:36 PM
Dadswell CharlesSVP & General CounselMar 22Sale416.24314130,6996,832Mar 24 04:41 PM
FLATLEY JAY TDirectorMar 16Sale421.064,0001,684,240164,933Mar 18 07:20 PM
TOUSI SUSAN HSVP Product DevelopmentMar 05Sale402.24800321,79244,943Mar 09 05:29 PM
FLATLEY JAY TDirectorMar 02Sale444.614,0001,778,440168,933Mar 04 05:04 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 18Sale486.75666324,1761,538Feb 22 05:11 PM
TOUSI SUSAN HSVP Product DevelopmentFeb 17Option Exercise0.006,306048,921Feb 18 04:52 PM
SAMAD SAMSVP and CFOFeb 17Option Exercise0.004,37909,355Feb 18 04:51 PM
RAGUSA ROBERT PSVP, Global Quality & OpsFeb 17Option Exercise0.006,306012,795Feb 18 04:49 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 17Option Exercise0.0093502,576Feb 18 04:47 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 17Option Exercise0.004,62508,873Feb 18 04:45 PM
Febbo Phillip G.SVP Chief Medical OfficerFeb 17Option Exercise0.003,17307,046Feb 18 04:44 PM
deSouza Francis APresident and CEOFeb 17Option Exercise0.0024,521085,934Feb 18 04:42 PM
Dadswell CharlesSVP & General CounselFeb 17Option Exercise0.003,50308,781Feb 18 04:41 PM
FLATLEY JAY TDirectorFeb 16Sale495.09500247,5433,500Feb 18 07:08 PM
FLATLEY JAY TDirectorFeb 16Sale505.264,0002,021,040172,933Feb 18 07:08 PM
TOUSI SUSAN HSVP Product DevelopmentFeb 05Sale431.90800345,52039,713Feb 09 04:48 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 02Sale444.845725,3562,359Feb 03 05:00 PM
FLATLEY JAY TDirectorFeb 02Sale444.844,0001,779,360176,933Feb 03 04:58 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 02Sale444.847232,0281,538Feb 03 04:57 PM
deSouza Francis APresident and CEOFeb 01Sale439.783,0001,319,33052,603Feb 03 04:56 PM
TOUSI SUSAN HSVP Product DevelopmentJan 20Sale400.002,5001,000,00040,447Jan 21 04:40 PM
FLATLEY JAY TDirectorJan 19Sale382.484,0001,529,920180,933Jan 21 04:38 PM
Hoyt Aimee LSVP, Chief People OfficerJan 11Sale379.65271102,8852,359Jan 12 04:41 PM
TOUSI SUSAN HSVP Product DevelopmentJan 05Sale365.27300109,58142,947Jan 06 07:20 PM
FLATLEY JAY TDirectorJan 05Sale365.274,0001,461,080184,933Jan 06 07:19 PM
deSouza Francis APresident and CEOJan 04Sale370.513,0001,111,53755,540Jan 06 07:17 PM
FLATLEY JAY TDirectorDec 15Sale348.844,0001,395,360188,933Dec 16 06:07 PM
Hoyt Aimee LSVP, Chief People OfficerDec 14Sale345.00354122,1302,744Dec 16 06:05 PM
Ronaghi MostafaSVP, Entrepreneurial DevlopmtDec 10Sale338.585,0001,692,92280,162Dec 14 04:12 PM
TOUSI SUSAN HSVP Product DevelopmentDec 07Sale349.34300104,80343,247Dec 08 05:34 PM
TOUSI SUSAN HSVP Product DevelopmentDec 04Sale350.0020070,00043,547Dec 08 05:34 PM
Dadswell CharlesSVP & General CounselDec 01Sale323.861,694548,6193,460Dec 02 05:48 PM
deSouza Francis APresident and CEODec 01Sale327.953,000983,85158,540Dec 02 05:45 PM
TOUSI SUSAN HSVP Product DevelopmentDec 01Sale325.0010032,50043,747Dec 02 05:41 PM
FLATLEY JAY TDirectorDec 01Sale323.904,0001,295,590192,933Dec 02 05:37 PM
RAGUSA ROBERT PSVP, Global Quality & OpsNov 30Sale314.822,890909,8274,092Dec 02 05:34 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerNov 18Sale300.0021865,4001,538Nov 19 04:16 PM
FLATLEY JAY TDirectorNov 17Sale297.163,000891,470196,933Nov 19 04:18 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerNov 06Sale310.1031296,7511,872Nov 09 05:40 PM
Hoyt Aimee LSVP, Chief People OfficerNov 06Sale310.1021566,6723,098Nov 09 05:39 PM
Febbo Phillip G.SVP Chief Medical OfficerNov 06Sale310.1015548,0662,143Nov 09 05:35 PM
FLATLEY JAY TDirectorNov 03Sale297.343,000892,010199,933Nov 04 04:43 PM
deSouza Francis APresident and CEONov 02Sale300.283,000900,85265,840Nov 04 04:39 PM
Dadswell CharlesSVP & General CounselNov 02Sale298.0012136,0586,036Nov 04 04:34 PM
FLATLEY JAY TDirectorOct 20Sale321.714,0001,286,860202,933Oct 22 03:47 PM
TOUSI SUSAN HSVP Product DevelopmentOct 12Sale350.0020070,00044,968Oct 14 04:07 PM
TOUSI SUSAN HSVP Product DevelopmentOct 07Sale325.0010032,50045,168Oct 08 05:21 PM
FLATLEY JAY TDirectorOct 07Sale324.011,000324,010206,933Oct 08 05:18 PM
FLATLEY JAY TDirectorOct 06Sale317.793,000953,370207,933Oct 07 04:49 PM
deSouza Francis APresident and CEOOct 01Sale308.783,000926,33168,840Oct 05 05:14 PM
Dadswell CharlesSVP & General CounselOct 01Sale312.8212137,8516,157Oct 05 05:11 PM